china glp-1 Approval of Ecnoglutide Expands Competition in the Obesity Market China GLP-1 Agonists Weight Loss

GLP-1R signaling and functional molecules in incretin therapy

The active ingredient may not be what you think it is Some compounded GLP-1 products use what's called a salt form of the active ingredient, like "semaglutide sodium" or "semaglutide acetate." These are not the same chemical entity as the FDA-approved semaglutide base used in Ozempic and Wegovy

Since muscle is metabolically active, losing it slows metabolism and increases the risk of weight regain when stopping GLP-1 treatment

Some clinicians are prescribing tirzepatide to breastfeeding mothers based on its molecular similarity to GLP-1, its large molecular weight (which reduces breast milk transfer), and the favorable animal data

Employer Insurance Coverage of GLP-1 Medications Most Americans under 65 get health coverage through an employer, making employer plan decisions the largest single determinant of GLP-1 access

Strategic differentiation beyond efficacy and pricing is essential as GLP-1 shifts from class-based to brand-based competition, requiring companies to refine positioning, branding (e.g., dual vs